- 询价
- 2026年09月25日
15 年金牌会员
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发，品质稳、品类全，实验不再等！Takara 秋促来袭，提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ￥1200阿拉丁 22万+ 科研级产品现货速发，品质严控、科研无忧- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 细胞形态：
淋巴样
- 库存：
大量
- 运输方式：
冻存运输
- 年限：
50 years
- 生长状态：
悬浮生长，多细胞聚集
- 物种来源：
人
- 是否是肿瘤细胞：
1
- 细胞类型：
其他细胞类型
- 相关疾病：
其他疾病
- ATCC Number：
CRL-2407™
| Designations: | NK-92 | ||
| Depositors: | Conkwest Inc. | ||
| Biosafety Level: | 2 | ||
| Shipped: | frozen | ||
| Medium & Serum: | See Propagation | ||
| Growth Properties: | suspension, multicell aggregates | ||
| Organism: | Homo sapiens deposited as human | ||
| Morphology: | lymphoblast |
||
| Source: | Disease: malignant non-Hodgkin's lymphoma Cell Type: natural killer cell; NK cell; |
||
| Permits/Forms: | In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. | ||
| Applications: | transfection host | ||
| Antigen Expression: | CD2 +, CD7 +, CD11a +, CD28 + , CD45 +, CD54 +, CD56 +, CD1 -, CD3 -, CD4 -, CD5 -, CD8 -, CD10 -, CD14 -, CD16 -, CD19 -, CD20 -, CD23 -, CD34 -, HLA-DR - | ||
| DNA Profile (STR): | Amelogenin: X,Y CSF1PO: 11,12 D13S317: 9,12 D16S539: 11,12 D5S818: 12,13 D7S820: 10,11 THO1: 6,9.3 TPOX: 8 vWA: 18 |
||
| Age: | 50 years | ||
| Gender: | male | ||
| Ethnicity: | Caucasian, White | ||
| Comments: | NK-92 is an interleukin-2 (IL-2) dependent Natural Killer Cell line derived from peripheral blood mononuclear cells from a 50 year old Caucasian male with rapidly progressive non-Hodgkin's lymphoma. [38894 ] The cell line is dependent on the presence of recombinant Il-2 and a dose as low as 10 U/ml is sufficient to maintain proliferation; cells will die within 72 hours in the absence of IL-2. [38894 ] The cell line is cytotoxic to a wide range of malignant cells; it kills both K562 cells and Daudi cells in chromium release assays. [38894 ] NK-92 cells (after irradiation to prevent proliferation) can be used effectively for immunological ex vivo purging of leukemia from blood without compromising hematopoietic cell function. [38896 ] NK-92 cells have the following characteristics: surfacemarker positive for CD2, CD7, CD11a, CD28, CD45, CD54 and CD56 bright; surface marker negative for CD1, CD3, CD4,CD5, CD8, CD10, CD14, CD16, CD19, CD20, CD23, CD34 and HLA-DR. [38894 ] |
||
| Propagation: | ATCC complete growth medium: The base medium for this cell line is Alpha Minimum Essential medium without ribonucleosides and deoxyribonucleosides but with 2 mM L-glutamine and 1.5 g/L sodium bicarbonate . To make the complete growth medium, add the following components to the base medium: 0.2 mM inositol; 0.1 mM 2-mercaptoethanol; 0.02 mM folic acid; 100-200 U/ml recombinant IL-2; adjust to a final concentration of 12.5% horse serum and 12.5% fetal bovine serum. Atmosphere: air, 95%; carbon dioxide (CO2), 5% Temperature: 37.0°C Growth Conditions: Successful growth of this cell line is very dependent upon the quality of IL-2 used in the growth medium. ATCC recommends using the highest quality IL-2 available. |
||
| Subculturing: | Protocol: Cultures can be maintained by addition or replacement of medium. When replacing media, centrifuge cells and resuspend cell pellet in fresh medium at 2 to 3 X 10(5) viable cells/ml. Pipet the cells up and down on the back of the flask every 2-3 days to produce a single cell suspension. NK-92 cells are extremely sensitive to overgrowth and media exhaustion. Medium Renewal: Replace with fresh medium every 2 to 3 days (depending on cell density) |
||
| Preservation: | Freeze medium: 50% FBS; 40% complete growth medium ; 10% DMSO. Storage temperature: liquid nitrogen vapor phase |
||
| Related Products: | recommended serum:ATCC 30-2020 recommended serum:ATCC 30-2040 derivative:ATCC CRL-2408 |
||
| References: | 38894: Gong JH, et al. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8: 652-658, 1994. PubMed: 8152260 38896: Klingemann HG, et al. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood. Biol. Blood Marrow Transplant. 2: 68-75, 1996. PubMed: 9118301 38969: Tam YK, et al. Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum. Gene Ther. 10: 1359-1373, 1999. PubMed: 10365666 39852: Klingemann HG, Miyagawa B. Purging of malignant cells from blood after short ex vivo incubation with NK-92 cells. Blood 87: 4913-1914, 1996. PubMed: 8639869 39854: Komatsu F, Kajiwara M. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells. Oncol. Res. 10: 483-489, 1998. PubMed: 10338151 39855: Yan Y, et al. Antileukemia activity of a natural killer cell line against human leukemias. Clin. Cancer Res. 4: 2859-2868, 1998. PubMed: 9829753 39857: Maki G, et al. Induction of sensitivity to NK-mediated cytotoxicity by TNF-alpha treatment: possible role of ICAM-3 and CD44. Leukemia 12: 1565-1572, 1998. PubMed: 9766501 39861: Nagashima S, et al. Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo. Blood 91: 3850-3861, 1998. PubMed: 9573023 40184: Tam YK, et al. Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92. J. Hematother. 8: 281-290, 1999. PubMed: 10417052 |
||
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
询价记录
暂无询价记录
文献和实验相关实验
NK-92为人恶性非霍奇金淋巴瘤患者的自然杀伤细胞，属于IL-2依赖型NK细胞系。是NK细胞功能研究、CAR-NK工程化改造及免疫治疗机制探索的常用悬浮模式细胞，细胞聚团生长，边缘清晰、折光性强。细胞增殖依赖重组IL-2，缺少IL-2的细胞会在72 h内死亡。本文将针对NK-92的细胞培养流程进行梳理和指导。 一、细胞复苏 1.【准备工作】水浴锅提前预热至37℃；9mL完全培养基37℃预热；生物安全柜紫外照射灭菌30min； 2.【融化】液氮取出冻存管，37℃水浴快速摇晃融化，约1-2
【第92期】前沿靶点速递：每周医学研究精选 01 靶点：GPSM1 应用：为肥胖治疗提供了新靶点 来源：GPSM1 restricts CD73+CD103+ Treg cells in adipose tissue, critical for promoting obesity-relatedmetabolic deterioration.Nat Commun,2026 May 25 图源： 10.1038/s41467-026-73349-w[1] 上海市第六人民医院胡承、贾伟
NK细胞又称为自然杀伤细胞，属于大颗粒淋巴细胞，来源于骨髓，占外周血淋巴细胞的5%~15%，是重要的免疫细胞。科学家在1975年首次鉴定到了NK细胞，这类细胞能够在缺少T、B细胞的情况下直接杀伤肿瘤细胞。与具有细胞毒性的CD8+T细胞不同，NK细胞杀伤肿瘤细胞时不需要预先致敏可以直接杀伤MHC阴性的肿瘤细胞，这使得NK细胞在过继细胞免疫治疗中被广泛应用。但NK细胞在外周血淋巴细胞中所占的比例较低，所以有必要建立一种NK细胞体外扩增技术，用于研究NK细胞的功能并为肿瘤的细胞免疫治疗奠定
技术资料暂无技术资料 索取技术资料
NK-92
询价
